Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoff D.E. Cuvelier, Kirk R. Schultz, Joseph H. Chewning et al.|Blood|2019Cited by 89
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R. Schultz, Geoff D.E. Cuvelier, Amina Kariminia et al.|Blood|2020Cited by 67
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Michael R. Loken et al.|Transplantation and Cellular Therapy|2018Cited by 44
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoff D.E. Cuvelier, Kirk R. Schultz, Bernard Ng et al.|Blood Advances|2022Cited by 26
Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantationBernard Ng, Kirk R. Schultz, Andrew C. Harris et al.|Blood|2025Cited by 5